Tricuspid valve biopsy: A potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves

Journal of Heart Valve Disease

Volumn 12, Issue 2, 2003, Pages 264-269

  Maish, Mary S ^a,b   Hoffman Kim, Diane ^a   Krueger, Paula M ^a   Souza, Jason M ^a   Harper III, James J ^a   Hopkins, Richard A ^a  

^a BROWN UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; CHONDROITIN SULFATE; FIBRONECTIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE; ARTICLE; BIOPSY; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CHORDA TENDINEA RUPTURE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEART MUSCLE CELL; HEART TAMPONADE; IMMUNOCYTOCHEMISTRY; MALE; MORTALITY; MYOFIBROBLAST; NONHUMAN; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PULMONARY VALVE; RELIABILITY; SUPERIOR CAVA VEIN; SURVIVAL RATE; TISSUE ENGINEERING; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE;

ACTINS; ANIMALS; BIOPSY; CELLS, CULTURED; CHONDROITIN SULFATES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EOSINE YELLOWISH-(YS); EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; FLUORESCENT DYES; HEMATOXYLIN; IMMUNOHISTOCHEMISTRY; MALE; MODELS, CARDIOVASCULAR; MYOCYTES, CARDIAC; SHEEP; STAINING AND LABELING; TISSUE ENGINEERING; TRICUSPID VALVE; UNITED STATES; VIMENTIN;

EID: 0037360611     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Schoen FJ. Future directions in tissue heart valves: Impact of recent insights from biology and pathology. J Heart Valve Dis 1999;8:350-358
2. Schoen FJ, Levy RJ. Tissue heart valves: Current challenges and future research perspectives. J Biomed Mater Res 1999;47:439-465
3. Vacanti JP, Langer R. Tissue engineering: The design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 1999;354(suppl.1):S132-S134
4. Shinoka T, Shum-Tim D, Ma. PX, et al. Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 1997;96(suppl.II):II-102-II-107
5. Hoerstrup SP, Zund G, Schoeberlein A, Ye Q, Vogt PR, Turina MI. Fluorescence activated cell sorting: A reliable method in tissue engineering of a bioprosthetic heart valve. Ann Thorac Surg 1998;66:1653-1657
6. Stock U, Nagashima M, Khalil PN, et al. Tissue-engineered valve conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000;119:732-740
7. Zund G, Ye Q, Schoeberlein A, et al. Tissue engineering in cardiovascular surgery: MTT, a rapid and reliable quantitative method to assess the optimal human cell seeding on polymeric meshes. Eur J Cardiothorac Surg 1999;15:519-524
8. Sodian R, Hoerstrup SP, Sperling JS, et al. Tissue engineering of heart valves: In vitro experiences. Ann Thorac Surg 2000;70:140-144
9. Ye Q, Zund G, Jockenhoevel S, Schoeberlein A, Hoerstrup SP, Grunenfelder J. Scaffold precoating with human autologous extracellular matrix for improved cell attachment in cardiovascular tissue engineering. Am Soc Artif Intern Ograns J 2000;46:730-733
10. Rothenburger M, Visacher P, Volker W, Glasmacher B, Berendes E, Scheld HH. In vitro modeling of tissue using isolated vascular cells on a synthetic collagen matrix. Thorac Cardiovasc Surg 2001;49:204-209
11. Schnell AM, Hoerstrup SP, Zund G, Kolb S, Sodian R, Visjager JF. Optimal cell source for cardiovascular tissue engineering: Venous vs. aortic human myofibroblasts. Thorac Cardiovasc Surg 2001;49:221-225
12. Zeltinger J, Landeen LK, Alexander HG, Kidd ID, Sibanda B. Development and characterization of tissue-engineered aortic valves. Tissue Eng 2001;7:9-22
13. Messier R, Jr., Bass B, Aly H, Jones J, Domkowski P, Wallace R, Hopkins R. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: Characteristics of the leaflet myofibroblast. J Surg Res 1994;57:1-21
14. Lester W, Rosenthal A, Granton B, Gotlieb AI. Porcine mitral valve interstitial cells in culture. Lab Invest 1988;59:710-719
15. Filip DA, Radu A, Simionescu M. Interstitial cells of the heart valves possess characteristics similar to smooth muscle cells. Circ Res 1986;59:310-319
16. Zacks S, Rosenthal A, Granton B, Havenith M, Opas M, Gotlieb AI. Characteristic of cobblestone mitral valve interstitial cells. Arch Pathol Lab Med 1991;115:774-779
17. Hoerstrup SP, Zund G, Ye Q, Schoeberlein A, Schmid AC, Turina MI. Tissue engineering of a bioprosthetic heart valve: Stimulation of extracellular matrix assessed by hydroxyproline assay. Am Soc Artif Intern Organs J 1999;45:397-402
18. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102(19 Suppl.3):III44-III49
19. Sodian R, Hoerstrup SP, Sperling JS, Martin DP, Daebritz S, Mayer JE, Jr. Evaluation of biodegradable three-dimensional matrices for tissue engineering of heart valves. Am Soc Artif Intern Organs J 2000;46:107-110